Skip to main content
SpringerLink
Log in

Intensivmedizinische Behandlung des akuten Herzinfarktes in den ersten Tagen

  • Conference paper
91. Kongreß

Part of the book series: Verhandlungen der Deutschen Gesellschaft für innere Medizin ((VDGINNERE,volume 91))

  • 17 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. A Multicentre International Study: Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol (1975) Br Med J 1:735–740 —

    Google Scholar 

  2. A Multi-centre International Study: supplementary report. Reduction in mortality after myocardial infarction with long-term beta-adrenoreceptor blockade (1977) Br Med J 2:419–421 —

    Google Scholar 

  3. Andersen MP, Bechsgaard P, Frederiksen Jet al. (1979) Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. Lancet 2:865–869 —

    Google Scholar 

  4. Behn P, Horn I (1972) Der Einfluß einer Hypertonie auf die Prognose beim akuten Myokardinfarkt. Ber Ges In Med 8:232 —

    Google Scholar 

  5. Beta-Blocker Heart Attack Trial Research Group (1982) A randomized trial of propanolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247:1707–1714 —

    Google Scholar 

  6. Bleifeld W (1977) Der Herzinfarkt. Unsere heutigen Kenntnisse und zukünftigen Aussichten. Triangel 16:69 —

    Google Scholar 

  7. Bodenheimer MM, Ramanathan K, Banka VS, Helfant RH (1981) Effect of progressive pressure reduction with Nitroprusside on acute myocardial infarction in humans. Ann of Intern Medic 94:435 —

    Google Scholar 

  8. Büyüköztürk K, Gültekin N, Deligönül U, Özkan E, Korkut F, Meric M, Erzengin F, Özcan R (1980) Acute systolic hypertension after acute myocardial infarction. Acta Cardiologica 5:341 —

    Google Scholar 

  9. Christensen DI, Ford M, Reading J. Castle CH (1977) Effect of hypertension on myocardial rupture after acute myocardial infarction. Chest 72:618–622 —

    Google Scholar 

  10. Dunn FG (1983) Hypertension and myocardial infarction. J Am Coll Cardiol 1 (2):528 —

    Google Scholar 

  11. Dye LE, Urthaler F, MacLean WAH, Russel RO, Rackley CE, James TN (1978) New arterial hypertension during myocardial infarction. South Med J 71:289 —

    Google Scholar 

  12. Forrester JS, Diamond GA, Swan HJC (1977) Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Amer J Cardiol 39:137 —

    Google Scholar 

  13. Fox KM, Tomlinson IW, Portal RW, Aber CP (1975) Prognostic significance of acute systolic hypertension after myocardial infarction. Brit Med J 3:128 —

    Google Scholar 

  14. Gibson TC (1978) Blood pressure levels in acute myocardial infarction. Amer Heart J 96:475 —

    Google Scholar 

  15. Golikov AP, Ileva VI, Malaev G (1982) Humoral mechanism of arterial hypertension in patients in the acute phase of myocardial infarction. Cor Vasa 24:329 —

    Google Scholar 

  16. Gordon GD, Mabin TA, Isaacs S, Lloyd EA, Eichler HG, Opie LH (1984) Hemodynamic effects of sublinguale Nifedipine in acute cardial infarction. Am J Cardiol 53:1228 —

    Google Scholar 

  17. Gunnar RM, Loeb HS, Scanlon PJ, Moran JF, Johnson SA, Pifarre R (1979) Management of acute myocardial infarction and accelerating angina. Progr Cardiovasc Dis 22:1 —

    Google Scholar 

  18. Hjalmarson A, Elmfeldt D, Herlitz J et al. (1981) Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomized trial. Lancet 2:823–827 —

    Google Scholar 

  19. James TN, Isobe JH, Urthaler F (1975) Analysis of components in a cardiogenic hypertensive chemoreflex. Circulation 52:179–192 —

    Google Scholar 

  20. Julian DG, Jackson FS, Prescott RJ, Szekely P (1982) Controlled trial of sotalol for one year after myocardial infarction. Lancet 1:1142–1147 —

    Google Scholar 

  21. Lohmann FW, Dissmann T, Horn J (1973) Hypertonie und Myokardinfarkt unter besonderer Berücksichtigung des Blutdruckverhaltens nach dem Infarkt. Z F Kardiol 63:252 —

    Google Scholar 

  22. Mäurer W, Mehmel HC, Kübler W (1983) Die Therapie des akuten Myokardinfarktes. Internist 23:283 —

    Google Scholar 

  23. Melandri G, Bassein L, Petronelli FP, Tartagni F, Maresta A, Magnani B (1983) Intrahospital prognosis of acute myocardial infarction by means of discriminant analysis. G Ital Cardio 13:1 —

    Google Scholar 

  24. Norwegian Multicenter Study Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801–807 —

    Google Scholar 

  25. Oliver MF (1975) Acute systolic hypertension during myocardial infarction. Brit Med J 3:432 —

    Google Scholar 

  26. Pantridge JF, Webb SW, Adgey AAJ, Geddes JS (1974) The first hour after the onset of acute myocardial infarction. In: Yu PN, Goodwin JF (eds) Progress in Cardiol. Lea and Febiger, Philadelphia, pp 65–198 —

    Google Scholar 

  27. Renard M, Reviere P, Jacobs R, Bernard (1938) Treatment of Hypertension in acute stage of myocardial infarction. Br Heart J 49:522 —

    Google Scholar 

  28. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagosis heart disease. (1979) Circulation 59:607 —

    Google Scholar 

  29. Rudolph W, Dirschinger J (1981) Standardtherapie des akuten Herzinfarktes. Herz 6:25 —

    Google Scholar 

  30. Schuster P (1983) Isosorbiddinitrat oral bei akutem Myokardinfarkt. Habilitationsschrift Ruhr-Universität Bochum —

    Google Scholar 

  31. Spang K (1962) Kardiale Komplikationen der essentiellen Hypertonie. Verh Ges Kreislaufforschung 28:127–137 —

    Google Scholar 

  32. Vedin A, Hjalmarson A, Wilhelmsson C (1984) Auswirkungen auf die Letalität und Messungen der Infarktgröße nach Behandlung mit Beta-1-Selektiven und nicht selektiven Betablockern. In: Lohmann FW (ed) Die klinische Bedeutung der Beta-1-Selektivität. Verlag für angewandte Wissenschaften, München, S 113–133 —

    Google Scholar 

  33. Vetter NJ, Strange RC, Adams N, Oliver MF (1974) Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1:284–288 —

    Google Scholar 

  34. Wiechmann HW, Sturm A (1983) Interaktionen und Inkompatibilitäten bei Anwendung von Antihypertensiva. Intensivmedizin 20:56 —

    Google Scholar 

  35. Wirtzfeld A, Klein G, Delius W, Sack D (1978) Behandlung des akuten Myokardinfarktes mit Metoprolol. Dtsch med Wochenschr 103:566 —

    Google Scholar 

  36. Yusuf S, Ramsdale D, Peto R, Furse L, Bennett D, Bray C, Sleight P (1980) Early intravenous atenolol treatment in suspected acute myocardial infarction. Lancet 1: 273

    Google Scholar 

  37. Achuff SC, Campbell RWF, Pottage A, Murray A, Prescott L, Julian DG (1975) Mexiletin zur Prävention ventrikulärer Arrhythmien bei akutem Herzinfarkt. Circ 147: 51–52 —

    Google Scholar 

  38. Achuff SC, Campbell RWF, Pottage A, Murray A, Prescott L, Julian DG (1977) Mexiletine in the prevention of ventricular arrhythmias in acute myocardial infarction. Postgrad med J 53:163–164 —

    Google Scholar 

  39. Ahnve S, Helmers C, Lundman T, Rehnqvist N, Sjögren A (1980) QTC Intervals in acute Myocardial Infarction: First-Year Prognostic Implications. Clin Cardiol 3:303–308 —

    Google Scholar 

  40. Balcon R, Jewitt DE, Davies JPH, Oram S (1966) A Controlled Trial of Propranolol in acute Myocardial Infarction. Lancet:918–924 —

    Google Scholar 

  41. Bennett MA, Wilner JM, Pentecost BL (1970) Controlled Trial of Lignocaine in Prophylaxis of ventricular Arrhythmias Complicating Myocardial Infarction. Lancet:909–911 —

    Google Scholar 

  42. Bloomfield SS, Romhilt DW, Te-Chuan Chou, Fowler NO (1971) Quinidine for Prophylaxis of Arrhythmias in acute Myocardial Infarction. N Engl J Med 285:980–986 —

    Google Scholar 

  43. Bussmann WD, Neumann K, Kaltenbach M (1984) Effects of intravenous nitroglycerin on ventricular ectopic beats in acute Myocardial Infarction. Am Heart J 107:940–944 —

    Google Scholar 

  44. Campbell RWF, Dolder MA, Prescott LF, Talbot RG, Murray A, Julian DG (1977) Ventricular arrhythmias after acute Myocardial Infarction treated with procainamide or mexiletine. Postgrad Med J 53:150–153 —

    Google Scholar 

  45. Campbell RWF, Bryson LG, Bailey BJ, Murray A, Julian DG (1979) Oral Tocainide in Suspected Acute Myocardial Infarction. Abstr Circ 59 and 60 (Supp II):70 —

    Google Scholar 

  46. Cohen LS, Conde CA (1978) Ventricular Dysrhythmias during the Hyperacute, Acute and Convalescent Phases of Myocardial Infarction. In: Donoso E, Lipski J (eds) Acute Myocardial Infarction. Stratton Intercontinental Medical Book Corporation, New York, p 112 —

    Google Scholar 

  47. Coker SJ, Parrat JR (1983) Thromboxane and Prostacyclin in the Genesis of Reperfusion Arrhythmias. Euro H J 4, Supp 3:55 —

    Google Scholar 

  48. Cooper WD, Kuan P, Reuben SR, Vendenburg J (1984) Cardiac arrhythmias following acute myocardial infarction: Associations with the serum potassium level and prior diuretic therapy. Euro H J 5:464–469 —

    Google Scholar 

  49. Donoso E, Lipski J (1978) Bradyarrhythmias and Ventricular Conduction Blocks Complicating Acute Myocardial Infarction. Role of Pacemakers. In: Donoso E, Lipski J (eds) Acute Myocardial Infarction. Stratton Intercontinental Medical Book Corporation, New York, p 169 —

    Google Scholar 

  50. Dubner S, Gimeno G, Elencwajg B, Quinteiro R, Tronge J, Bertolasi C (1982) Antiarrhythmic Effect of Tiapamil in Patients with Acute Myocardial Infarction. Card 69:172–180 —

    Google Scholar 

  51. Erhl G, Kloner RA, Alexander RW, Braunwald E (1982) Limitation of experimental infarct size by an angiotensin converting enzyme inhibitor. Circ 65:40–48 —

    Google Scholar 

  52. Follath F, Ritz R, Vozeh S, Wenk M (1982) Verlangsamte Lidocain-Elimination and Dosisanpassung bei Patienten mit Herzinsuffizienz. Schweiz med Wochenschr 112:789–792 —

    Google Scholar 

  53. Grande P, Pedersen A (1984) Myocardial infarct size: correlation with cardiac arrhythmias and sudden death. Eur H J 5:622–627 —

    Google Scholar 

  54. Gülker H, Thale J, Heuer H, Rose D, Bender F (1984) Comparative Antiarrhythmic action of Diltiazem during earl and late phase ventricular arrhythmias. Eur Heart J 4 (Supp E):56 —

    Google Scholar 

  55. Haerten K, Schepers J, Borggrefe M, Abendroth RR, Seipel L, Breithardt G (1984) Häufigkeit and prognostische Bedeutung auslösbarer ventrikulärer Arrhythmien im frühen Postinfarktstadium. Z Kardiol 73:199–205 —

    Google Scholar 

  56. Herlitz J, Edvardsson N, Holmberg S, Rydén L, Waagstein F, Waldenström A, Swedberg K, Hjalmarson A (1984) Göteborg Metoprolol Trial: Effects on Ar-

    Google Scholar 

  57. rhythmias. Am J Cardiol 53:27–31 —

    Google Scholar 

  58. Hust MH, Nitsche K, Löllgen H (1982) QT-Verlängerung im Oberflächen-EKG — was steckt dahinter? Herz + Gefäße 2:244–246 —

    Google Scholar 

  59. Hust MH, Löllgen H, Just H (1983) QT-Anomalien und Arrhythmien durch Antiarrhythmika. Med Klin 78:728–731 —

    Google Scholar 

  60. Hust MH, Heilmann S, Bonzel T, Hohnloser S, Zeiher A, Berchtold-Kanz E, Wollschläger H, Just H (1984) Prognostische Bedeutung des QT-Intervalls nach Herzinfarkt. Schweiz med Wochenschr 114:56–58 —

    Google Scholar 

  61. Jennings G, Jones MBS, Bestermann EMM, Model DG, Turner PP, Kidner PH (1976) Oral Disopyramide in Prophylaxis of Arrhythmias following Myocardial Infarction. Lancet:51–54 —

    Google Scholar 

  62. Kertes M, Glabus A, Murray A, Julian DG, Campbell RWF (1984) Delayed ventricular depolarization-correlation with ventricular activation and relevance to ventricular fibrillation in acute myocardial infarction. Eur Heart J 5:974–983 —

    Google Scholar 

  63. Klein MD, Levine PA, Ryan TJ (1980) Antiarrhythmic Efficacy, Pharmacokinetics and Clinical Safety of Tocainide in Convalescent Myocardial Infarction Patients. Chest 77:726–730 —

    Google Scholar 

  64. Koch-Weser J, Klein SW, Foo-Canto LL, Kastor JA, DeSanctis RW (1969) Antiarrhythmic Prophylaxis with Procainamide in acute Myocardial Infarction. N Engl J Med 281:1253–1260 —

    Google Scholar 

  65. Kramer JB, Corr PB (1984) Mechanisms contributing to arrhythmias during ischaemia and infarction. Eur Heart J 5:11–18 —

    Google Scholar 

  66. Lie KI, Wellens HJ, Van Capelle FJ, Durrer D (1974) Lidocaine in the Prevention of Primary ventricular Fibrillation. N Engl J Med 1324–1326 —

    Google Scholar 

  67. Lucchesi BR (1984) Rationale of Therapy in the Patient with Acute Myocardial Infarction and Life-Threatening Arrhythmias: A Focus on Bretylium. Am J Cardiol 54:14–19 —

    Google Scholar 

  68. Luderitz B, Naumann D’Alnoncourt C (1983) Antiarrhythmische Therapie bei Herzinfarkt. In: Herzrhythmusstörungen B. Luderitz Handbuch der Inneren Medizin. Springer, Berlin Heidelberg New York, p 897 —

    Google Scholar 

  69. Michorowski B, Ceremuzynski L (1983) The renin-angiotensin-aldosterone system and the clinical course of acute myocardial infarction. Eur Heart J 4:259–264 —

    Google Scholar 

  70. Norris RM et al. (1984) Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet:883–886 —

    Google Scholar 

  71. Pitt A, Lipp H, Anderson ST (1971) Lignocaine given prophylactically to patients with acute myocardial infarction. Lancet:612–616 —

    Google Scholar 

  72. Potratz J, Djonlagie H, Mentzel H, 011mann D, Hackenjos B, Diederich KW (1984) Registrierung von Spätpotentialen bei akuten Infarktpatienten und ihre Beziehung vom Infarktalter, zum Auftreten von Herzrhythmusstörungen und zum plötzlichen Herztod. Intensivmed 21:211–212 —

    Google Scholar 

  73. Puddu PE, Jouve R, Torresani J, Jouve A (1979) Electrocardiographic antecedents of primary ventricular fibrillation: value of QT interval prolongation in acute myocardial infarction. In: Florence international meeting on myocardial infarction. Exerpta medica, Amsterdam 1979 —

    Google Scholar 

  74. Rochette L, Didier JP, Moreau D, Bralat J, Opie LH (1984) Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arrhythmias: effects of acebutolol, atenolol, and d-propranolol on isolated working rat hearts subject to myocardial ischemia and reperfusion. Am Heart J 107:1132–1141 —

    Google Scholar 

  75. Rehnqvist N (1983) Vergleich der Wirksamkeit von Rytmonorma und Lidocain bei Patienten mit akutem Myokardinfarkt und ventrikulären Extrasystolen — Ergebnis eines 24stündigen Holter-monitorings. In: Schlepper und Olsson Kardiale Rhythmusstörungen. Springer, Berlin Heidelberg New York, p 45 —

    Google Scholar 

  76. Schwartz PJ, Wolf S (1978) QT Intervall Prolongation as Predictor of Sudden Death in Patients with Myocardial Infarction. Circ 57:1074–1077 —

    Google Scholar 

  77. Tamari I, Rabinowitz B, Neufeld HN (1982) Torsade de pointes due to prenylamine controlled by lignocaine. Eur Heart J 3:309–392 —

    Google Scholar 

  78. Torresani J (1984) Bretylium Tosylate in Patients with Acute Myocardial Infarction. Am J Cardiol 54:21–25 —

    Google Scholar 

  79. Zainal N, Griffiths JW, Carmichael DJS, Bestermann EMM (1977) Oral Disopyramide for the Prevention of Arrhythmias in Patients with Acute Myocardial Infarction admitted to open wards. Lancet: 887–889

    Google Scholar 

  80. I. Akhtar N, Mikulic E, Cohn JN, Chaudhry MH (1975) Hemodynamic effect of Dobutamine in patients with severe heart failure. Am J Cardiol 36:202–205 —

    Google Scholar 

  81. Alcan KE, Stertzer SH, Wallsh E, Bruno MS, PePasquale NP (1984) Current status of intra-aortic balloon counterpulsation in critical care cardiology. Crit Care Med 12:489–495 —

    Google Scholar 

  82. Bassenge E (1982) Pharmakologische Basis der Therapie mit Molsidomin. Herz 7:296–306 —

    Google Scholar 

  83. Baumstark A, Swensson RG, Hessel SJ, Levin DC, Grossmann W, Mann JT, Abrams HL (1984) Evaluating the radiographic assessment of pulmonary venous hypertension in chronic heart disease. AJR 141: 877–884 —

    Google Scholar 

  84. Bayley S, Valentine H, Bennett ED (1984) The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure. Intensive Care Med 10:139–145 —

    Google Scholar 

  85. Benotti JR, Grossmann W, Braunwald E, Carabello BA (1980) Effects of Amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62:28–34 —

    Google Scholar 

  86. Benotti JR, McCue J, Love D, Alpert JS (1983) Comparative inotropic therapy in heart failure patients. Circulation 68 (Suppl. 3): III-128 —

    Google Scholar 

  87. Bleifeld W, Hanrath P (1975) Die hämodynamische Basis der Therapie des akuten Myokardinfarktes. Deutsch Med Wochenschr 100:1345 —1350 —

    Google Scholar 

  88. Braunwald E, Ross J (1963) The rentricular end-diastolic pressure: an appraisal of its value in the recognition of ventricular failure in man. Am J Med 34:147–150 —

    Google Scholar 

  89. Brodie BR, Grossmann W, Mann T, McLaurin LP (1977) Effects of sodium nitraprusside on left ventricular diastolic pressure volume relations. J Clin Invest 59:59–68 —

    Google Scholar 

  90. Buschmann HJ, Dissmann W, Siemon G, Sonderkamp H, Schröder R (1967) Die arterielle Hypoxämie bei akutem Myokardinfarkt. Klin Wochenschr 45:113–121 —

    Google Scholar 

  91. Bussmann WD, Wehrheim HG (1983) Therapie des kardiogenen Schocks mit Dobutamin und Nitroglycerin. Deutsch Med Wochenschr 108:1273–1280 —

    Google Scholar 

  92. Cantelli I, Lolli C, Brunetti A, Bracchetti D (1985) Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction. Am Heart J 109:716–719 —

    Google Scholar 

  93. Carlet J, Francoual M, Lhoste F, Regnier B, Lemaire F (1980) Pharmacological treatment of pulmonary oedema. Intensive Care Med 6:113–122 —

    Google Scholar 

  94. Crexells C, Chatterjee K, Forrester JS, Dikshit K, Swan HJC (1973) Optimal level of filling pressure in the left side of the heart in acute myocardial infarction. N Engl J Med 289:1263–1266 —

    Google Scholar 

  95. Cyran J, Bolte HD (1981) Parenterale Kombinationstherapie mit Katecholaminen und Vasodilatantien bei koronarer Herzkrankheit. In: Bolte HD (Hrsg) Katecholamine und Vasodilatantien bei Herzinsuffizienz. Springer, Berlin Heidelberg New York, S 55–63 —

    Google Scholar 

  96. Cyran J, Hellwig H, Bolte HD, Karabensch FJ, Scherpe A, v. Gosen J, Krüger R, Luderitz B (1978) zum Dosierungsproblem der Nitroglyzerindauerinfusion bei Patienten mit schwerer Herzinsuffizienz. Intensivmed 15:156–160 —

    Google Scholar 

  97. Cyran J, Kühnl C, Zähringer J, Bolte HD, Luderitz B (1978) Die Änderung der Hämodynamik des Herzens unter dem kombinierten Einfluß von Nitroglyzerin und Dopamin bei hochgradiger Linksherzinsuffizienz. Z Kardiol 67:759–765 —

    Google Scholar 

  98. Dawson JR, Poole-Wilson PA, Sutton GC (1980) Salbutamol in cardiogenic shock complicating acute myocardial infarction. Br Heart J 43:523–526 —

    Google Scholar 

  99. Drajer S, Vazquez A, Cercòs H, Torres H, Cohn JL, Romero N, Faerman G, Soifer S, Nijensohn CM (1985) Molsidomine in the treatment of acute heart failure. Am Heart J 109:712–715 —

    Google Scholar 

  100. Edwards JD (1985) Right ventricular infarction. In: Vincent JL (ed) Update in intensive care medicine. Springer, Berlin Heidelberg New York, S 236–237-

    Google Scholar 

  101. Effert S, Merx W, Meyer J (1982) Akutes Herzversagen, Lungenödem und Schock. Verh Deutsch Ges Inn Med 88:57–65-

    Google Scholar 

  102. Erbel R, Meyer J, Lambertz H, Schweizer P, Voelker W, Krebs W, Braun G, Effert S (1982) Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy. Circulation 66:361–369-

    Google Scholar 

  103. Fillmore SJ, Guimaràes AC, Scheidt SS, Killip T (1972) Blood-Gas changes and pulmonary hemodynamics following acute myocardial infarction. Circulation 45:583–591-

    Google Scholar 

  104. Fowler MB, Timmis AD, Crick JP, Vincent R, Chamberlain DA (1982) Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic chock after acute myocardial infarction. Br Med J 284:73–76-

    Google Scholar 

  105. Franciosa JA, Dunkman WB, Wilen M, Silverstein SR (1983) “Optimal” left ventricular filling pressure during Nitroprusside infusion for congestive heart failure. Am J Med 74:457–464-

    Google Scholar 

  106. Francis GS, Sharma B, Hodges M (1982) Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Am Heart J 103:995–1000-

    Google Scholar 

  107. Goldstein RA, Passamani ER, Roberts R (1980) A comparison of Digoxin and Dobutamine in patients with acute infarction and cardiac failure. N Engl J Med 303:846–850-

    Google Scholar 

  108. Hillen H, Lehmann HU, Hochrein H (1984) Hämodynamische Wirkungen von Prenalterol im Vergleich zum Dopamin und Dobutamin beim kardiogenen Schock. Intensivmed 21:72–76-

    Google Scholar 

  109. Hillen H, Witt E, Lehmann HU, Hochrein H (1981) Nitroglycerin, Dopamin und deren kombinierte Anwendung bei schwerer Myokardinsuffizienz. Intensivmed 18:11–16-

    Google Scholar 

  110. Hockings BEF, Cope GD, Clarke GM, Taylor RR (1982) Randomized controlled trial of vasodilator therapy after myocardial infarction. Am J Cardiol 48:345–352-

    Google Scholar 

  111. Jahrmärker H, Rackwitz R, Haider M (1977) Blutlaktat als Parameter zur Überwachung bei akutem Myokardinfarkt. In: Kaindl F, Pachinger O, Probst P (Hrsg) Die ersten 24 Stunden des Herzinfarktes. Witzstrock, Baden-Baden Köln New York, S 51–53-

    Google Scholar 

  112. Jennings K, Gwilt D, Crean P, Turnbull S, Gold R, Julian DG (1982) The clinical cardiovascular pharmacology of Amrinone. A selective cardiotonic agent. Acta Cardiol 1982 (Suppl 28):67–75-

    Google Scholar 

  113. Keung ECH, Siskind SJ, Sonnenblick H, Ribner HS, Schwartz WJ, LeJemtel TH (1981) Dobutamine therapy in acute myocardial infarction. JAMA 245:144–146-

    Google Scholar 

  114. Klein NA, Siskind SJ, Frishman WH, Sonnenblick EH, LeJemtel TH (1981) Hemodynamic comparison of intravenous Amrinone and Dobutamine in patients with chronic congestive heart failure. Am J Cardiol 48:170–175-

    Google Scholar 

  115. Klepzig M, Kleinhans E, Büll U, Strauer BE (1985) Amrinone in Akut-und Langzeittherapie. Z Kardiol 74:85–90-

    Google Scholar 

  116. Laggner A, Klein-berger G, Haller J, Lenz K, Sommer G, Druml W (1984) Bedside estimation of extravascular lung water in critically ill patients: comparison of the chest radiograph and the thermal dye technique. Intensive Care Med 10:309–313-

    Google Scholar 

  117. Laggner A, Kleinberger G, Graninger W, Lenz K, Druml W, Schneeweiß B (1985) Dynamik und prognostischer Wert des extravaskulären Lungenwassers bei Intensivpatienten. Intensivmed 22:94–97-

    Google Scholar 

  118. Lehmann HU, Polensky A, Hochrein H (1984) Isosorbid-5-Mononitrat (IS-5-MN) in der Therapie des akuten Myokardinfarktes. Intensivmed 21:77–83-

    Google Scholar 

  119. Leier CV, Heban PT, Huss P, Bush CA, Lewis RP (1978) Comparative systemic and regional hemodynamic effects of Dopamine and Dobutamine in patients with cardiomyopathie heart failure. Circulation 58:466–475-

    Google Scholar 

  120. Leier CV, Bambach D, Thompson MJ, Cattaneo SM, Goldberg RJ, Unverferth DV (1981) Central and regional hemodynamic effects of intravenous Isosorbide Dinitrate, Nitroglycerin and Nitroprusside in patients with congestive heart failure. Am J Cardiol 48:1115–1123-

    Google Scholar 

  121. LeJemtel TH, Keung E, Sonnenblick EH, Ribner HS, Matsumoto M, Davis R, Schwartz W, Alousi AA, Davolos D (1979) Amrinone: A new non-glycosidic, nonadrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 59:1098–1104-

    Google Scholar 

  122. Likoff MJ, Weber KT, Andrews V, Janicki JS (1983) Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure. Herz: 199–205-

    Google Scholar 

  123. Loeb HS, Bredakis J, Gunnar RM (1977) Superiority of Dobutamine or Dopamine for Augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55:375–381-

    Google Scholar 

  124. Loeb HS, Gunnar RM (1981) Treatment of pump failure in acute myocardial infarction. JAMA 245:2093–2096-

    Google Scholar 

  125. Loeb HS, Winslow EBJ, Rahimtoola SH, Rosen KM, Gunnar RM (1971) Acute hemodynamic effects of Dopamine in patients with shock. Circulation 44:163–173-

    Google Scholar 

  126. Mueller HS (1979) Myokardinfarkt - Kardiogener Schock. Intensivmed 16:115–121-

    Google Scholar 

  127. Nikki P, Räsänen J, Tahvanainen J, Mäkeläinen A (1982) Ventilatory pattern in respiratory failure arising from acute myocardial infarction. Crit Care med 10:75–78-

    Google Scholar 

  128. Nobis H, Enenkel W (1985) Der derzeitige Stand der intraaortalen Ballongegenpulsation. Intensivmed 22:61–68-

    Google Scholar 

  129. Nobis H, Prachar H, Enenkel W (1981) Respiratortherapie bei akutem Myokardinfarkt. Intensivmed 18:192–196-

    Google Scholar 

  130. Polensky A, Lehmann HU, Hochrein H (1983) Bedeutung des linksventrikulären Füllungsdruckes für die Herzleistung beim akuten Myokardinfarkt. Intensivmed 20:225–229-

    Google Scholar 

  131. Renard M, Jacobs P, Liebens I, Friart A, Bernard R (1985) Effects of Molsidomine on hemodynam-

    Google Scholar 

  132. ics and blood gases in acute myocardial infarction with left heart failure. Am Heart J 109:720–722 —

    Google Scholar 

  133. Reifart N, Neidl K, Kaltenbach M, Bussmann WD (1985) Hemodynamic effects of Molsidomine in patients with acute myocardial infarction. Am Heart J 109:708–712 —

    Google Scholar 

  134. Richard C, Ricome JL, Rimalho A, Bottineau G, Auzepy P (1983) Combined Hemodynamic effects of Dopamine and Dobutamine in cardiogenic shock. Circulation 67:620–625 —

    Google Scholar 

  135. Russel RO, Rachley CE, Pomba J, Hunt D, Polanin C, Volge HT (1970) Effects of increasing left ventricular filling pressure in patients with acute myocardial infarction. J Clin Invest 49:1539–1550 —

    Google Scholar 

  136. Schartl M, Dougherty C, Rutsch W, Schmutzler H (1985) Hemodynamic effects of Molsidomine, Isosorbide Dinitrate, and Nifedipine at rest and during exercise. Am Heart J 109:649–653 —

    Google Scholar 

  137. Schuster HP (1984) Beatmungstherapie bei Linksherzversagen. Notfallmedizin 7:156–163 —

    Google Scholar 

  138. Schuster HP (1984) Die hämodynamischen Auswirkungen der Überdruckbeatmung. Klin Wochenschr 62:56–64 —

    Google Scholar 

  139. Siegel LA, Keung E, Siskind SJ, Forman R, Feinberg H, Strom J, Epstathakis D, Sonnenblick EH, LeJemtel TH (1981) Beneficial effects of Amrinone-Hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure. Circulation 63:838–844-

    Google Scholar 

  140. Weber KT, Andrews V, Janicki JS, Wilson JR, Fishman AP (1981) Amrinone and exercise performance in patients with chronic heart failure. Am J Cardiol 48:164–169 —

    Google Scholar 

  141. Weiß B, Donat K, Ivens K, Schuchart J, Ziegler WJ (1984) Komplikationen und Reanimationserfolge bei akutem Herzinfarkt. Epidemiologische Untersuchung in einer Großstadt. Intensivmed 21:339–344 —

    Google Scholar 

  142. Wirtzfeld A, Klein G, Delius W, Himmler C, Vogler E, Davidson J (1978) Dopamin und Dobutamin in der Behandlung der schweren Herzinsuffizienz. Deutsch Med Wochenschr 103:1915–1921 —

    Google Scholar 

  143. Wolff G, Grädel E, Hasse J, Gasser D (1974) Günstige Auswirkungen der künstlichen Beatmung auf den großen und kleinen Kreislauf bei Linksherzinsuffizienz. Intensivmed 11:218–223 —

    Google Scholar 

  144. Worthley LIG, Tyler P, Moran JL (1985) A comparison of Dopamine, Dobutamine and Isoproterenol in the treatment of shock. Intensive Care Med 11: 13–19

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Krefeld, Deutschland

    K.-D. Grosser

  2. Berlin, Deutschland

    H. Hochrein

  3. Zentrum für Innere Medizin, Universität Gießen, Deutschland

    H. G. Lasch

  4. Medizinische Universitätsklinik, Ruhr-Universität Bochum - Marienhospital Herne, Deutschland

    A. Sturm, H. W. Wiechmann & M. Bitter

  5. Medizinische Universitäts-Klinik und Institut für Medizinische Chemie, Pregl-Laboratorium der Universität Graz, Deutschland

    W. Klein, E. Maurer & K. Vrécko

  6. Medizinische Klinik I, Städtisches Krankenhaus Hildesheim, Deutschland

    H.-P. Schuster

  7. Medizinisch-geriatrische Klinik, Kantonsspital Basel, Schweiz

    H. B. Stähelin

  8. Rheinische Landesklinik, Köln, Deutschland

    M. Bergener

  9. Universitätsklinik für Innere Medizin, Theodor Brucksch, Berlin, DDR

    G. Brüschke

  10. Dept. f. Innere Medizin, Universität Basel, Schweiz

    H. J. Fahrländer

  11. Med. Poliklinik Universitätsspital, Zürich, Schweiz

    R. Lüthy

  12. 3. Med. Abteilung, Städtisches Krankenhaus München Schwabing, Deutschland

    H. Mehnert

  13. Krankheiten der Bewegungsorgane, Medizinische Hochschule Hannover, Deutschland

    H. H. Raspe

  14. 1. Innere Abteilung, Krankenhaus Moabit, Berlin, Deutschland

    K. P. Schüren

  15. Münster, Deutschland

    H. Losse

  16. Würzburg, Deutschland

    K. Kochsiek

Authors
  1. K.-D. Grosser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Hochrein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. G. Lasch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Sturm
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. W. Wiechmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Bitter
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K. Vrécko
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H.-P. Schuster
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. B. Stähelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M. Bergener
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. G. Brüschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. H. J. Fahrländer
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. R. Lüthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. H. Mehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. H. H. Raspe
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. K. P. Schüren
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. H. Losse
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. K. Kochsiek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Humboldtstr. 14, D-6200, Wiesbaden, Deutschland

    Klaus Miehlke

Rights and permissions

Reprints and permissions

Copyright information

© 1985 J. F. Bergmann Verlag, München

About this paper

Cite this paper

Grosser, KD. et al. (1985). Intensivmedizinische Behandlung des akuten Herzinfarktes in den ersten Tagen. In: Miehlke, K. (eds) 91. Kongreß. Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 91. J.F. Bergmann-Verlag. https://doi.org/10.1007/978-3-642-85458-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85458-3_4

  • Publisher Name: J.F. Bergmann-Verlag

  • Print ISBN: 978-3-8070-0352-8

  • Online ISBN: 978-3-642-85458-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation